1. 5-Hydroxytryptophan Reduces Levodopa-Induced Dyskinesia via Regulating AKT/mTOR/S6K and CREB/ΔFosB Signals in a Mouse Model of Parkinson’s Disease
   Yujin Choi et al, 2023, Biomolecules & Therapeutics CrossRef
2. Angiotensin-converting enzyme inhibition prevents l-dopa-induced dyskinesia in a 6-ohda-induced mouse model of Parkinson's disease
   Hye-Yeon Park et al, 2024, European Journal of Pharmacology CrossRef
3. Naphthoquinones as a Promising Class of Compounds for Facing the Challenge of Parkinson’s Disease
   Thaís Barreto Santos et al, 2023, Pharmaceuticals CrossRef
4. Aerobic exercise modulates the striatal Erk/MAPK signaling pathway and improves LID in a mouse model of Parkinson's disease
   Fangyuan Zhou et al, 2024, Brain Research Bulletin CrossRef
5. Decrease of KATP channel expression through D3 receptor-mediated GSK3β signaling alleviates levodopa-induced dyskinesia (LID) in Parkinson's disease mouse model
   Yi-Ying Kuo et al, 2024, Life Sciences CrossRef